Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Pulmonary Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT04739150
What this trial is testing

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim
Not applicableUnknownNCT00168285
What this trial is testing

Pulmonary Rehabilitation in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease
The Alfred 56
Not applicableLooking for participantsNCT00515567
What this trial is testing

Explanted Lung Tissues With Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University of Chicago 90
Not applicableStudy completedNCT03438032
What this trial is testing

Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD

Who this might be right for
Fibrosis LungSystemic Sclerosis
Northwestern University 10
Very early researchNot Yet RecruitingNCT07359963
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Regend Therapeutics 12
Not applicableNot Yet RecruitingNCT06416163
What this trial is testing

FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtion

Who this might be right for
Interstitial Lung DiseaseFibrosis LungPulmonary Hypertension
Guy's and St Thomas' NHS Foundation Trust 160
Early research (Phase 1)Study completedNCT06160440
What this trial is testing

The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

Who this might be right for
Diopathic Pulmonary FibrosisPulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 55
Not applicableAvailableNCT05356052
What this trial is testing

Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon
Not applicableUnknownNCT05771740
What this trial is testing

Pulmonary Fibrosis Lung Sounds Study

Who this might be right for
Pulmonary FibrosisHealthy
Royal Devon and Exeter NHS Foundation Trust 100
Testing effectiveness (Phase 2)Study completedNCT02707640
What this trial is testing

Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 123
Large-scale testing (Phase 3)Looking for participantsNCT05943535
What this trial is testing

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
United Therapeutics 698
Not applicableActive Not RecruitingNCT07560189
What this trial is testing

IPF Longitudinal Natural History Study

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Assiut University 1,423
Large-scale testing (Phase 3)Study completedNCT01079143
What this trial is testing

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

Who this might be right for
Renal Interstitial Fibrosis
Novartis Pharmaceuticals 194
Testing effectiveness (Phase 2)Ended earlyNCT01203943
What this trial is testing

Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary FibrosisFibrosis+2 more
Celgene 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05060822
What this trial is testing

Phase ll Study of HEC585 in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sunshine Lake Pharma Co., Ltd. 270
Not applicableStudy completedNCT05716022
What this trial is testing

Hiatal Hernia and Pulmonary Involvement

Who this might be right for
Hiatal HerniaInterstitial Lung Disease
University of Virginia 14
Not applicableEnrolling By InvitationNCT07061873
What this trial is testing

Physical Exercise Program for Adults With Diffuse Interstitial Lung Disease in a Pulmonary Rehabilitation Context

Who this might be right for
Interstitial Lung Disease Due to Systemic Disease (Disorder)Interstitial Lung Disease in Patients With Rheumatoid ArthritisPulmonary Fibrosis
Universidad de La Frontera 29
Not applicableUnknownNCT05572346
What this trial is testing

Digital App for Telerehabilitation in Respiratory Diseases

Who this might be right for
Respiratory DiseaseAsthmaLong COVID+4 more
MedicAir Healthcare S.r.l. 30
Testing effectiveness (Phase 2)Ended earlyNCT05032066
What this trial is testing

Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Amgen 153
Early research (Phase 1)Not Yet RecruitingNCT07682337
What this trial is testing

Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male Subjects

Who this might be right for
Solid TumorObesityIdiopathic Pulmonary Fibrosis
SCBIO Inc. 74
Next Page